Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group by Rémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, Olivier Tournilhac, Emmanuel Gyan, Marie Pierre Moles, Abderrazak El Yamani, Jerome Cornillon, Jean François Rossi, Steven Le Gouill, Gérard Lepeu, Ghandi Damaj, Philippe Solal Celigny, Hervé Maisonneuve, Bernadette Corront, Jean Pierre Vilque, Philippe Casassus, Thierry Lamy, Marc Colonna, Philippe Colombat

Get full text